AbbVie Inc.
US ˙ NYSE ˙ US00287Y1091

SecurityABBV / AbbVie Inc.
InstitutionPrincipal Street Partners, LLC
Latest Disclosed Ownership36,983 shares
Latest Disclosed Value $ 8,043,462
Principal Street Partners, LLC reports 1.59% decrease in ownership of ABBV / AbbVie Inc.

On May 15, 2026 - Principal Street Partners, LLC filed a 13F-HR form disclosing ownership of 36,983 shares of AbbVie Inc. (US:ABBV) valued at $8,043,433 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 37,581 shares of AbbVie Inc.. This represents a change in shares of -1.59% during the quarter. The current value of the position is $8,030,119 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBVIE Common stock 00287Y109 36,983 -598 -1.59 8,043 -6.32 1.3129
2026-02-17 2025-12-31 13F ABBVIE Common stock 00287Y109 37,581 -1,970 -4.98 8,587 -6.24 1.4484
2025-11-14 2025-09-30 13F ABBVIE Common stock 00287Y109 39,551 -11,791 -22.97 9,158 -3.90 1.4615
2025-08-14 2025-06-30 13F ABBVIE Common stock 00287Y109 51,342 12,249 31.33 9,530 16.35 0.9345
2025-05-15 2025-03-31 13F ABBVIE Common stock 00287Y109 39,093 2,080 5.62 8,191 24.52 1.5234
2025-02-18 2024-12-31 13F ABBVIE Common stock 00287Y109 37,013 -4,479 -10.79 6,577 -17.06 1.2933
2024-11-13 2024-09-30 13F ABBVIE Common stock 00287Y109 41,492 -5,765 -12.20 7,931 -2.16 1.2967
2024-08-14 2024-06-30 13F ABBVIE Common stock 00287Y109 47,257 -84 -0.18 8,105 -2.46 1.4518
2024-05-15 2024-03-31 13F ABBVIE Common stock 00287Y109 47,341 9,037 23.59 8,310 40.00 1.5708
2024-02-07 2023-12-31 13F ABBVIE Common stock 00287Y109 38,304 -2,397 -5.89 5,936 -2.16 1.4321
2023-11-01 2023-09-30 13F ABBVIE Common stock 00287Y109 40,701 2,967 7.86 6,067 19.34 1.2020
2023-08-21 2023-06-30 13F/A-1 ABBVIE Common stock 00287Y109 37,734 -1,497 -3.82 5,084 -18.70 1.2083
2023-08-15 2023-06-30 13F ABBVIE Common stock 00287Y109 39,231 0 6,252 1.5801
2023-05-11 2023-03-31 13F ABBVIE Common stock 00287Y109 39,231 1,353 3.57 6,252 2.14 1.5801
2023-02-15 2022-12-31 13F ABBVIE Common stock 00287Y109 37,878 243 0.65 6,121 21.18 1.5424
2022-11-14 2022-09-30 13F ABBVIE Common stock 00287Y109 37,635 -116 -0.31 5,051 -12.64 1.3462
2022-08-15 2022-06-30 13F ABBVIE Common stock 00287Y109 37,751 -10,446 -21.67 5,782 -26.00 1.4978
2022-05-05 2022-03-31 13F Abbvie Common stock 00287Y109 48,197 -70 -0.15 7,813 19.56 1.7913
2022-02-07 2021-12-31 13F Abbvie Common stock 00287Y109 48,267 2,233 4.85 6,535 31.59 1.5730
2021-11-10 2021-09-30 13F Abbvie Common stock 00287Y109 46,034 -687 -1.47 4,966 -5.64 1.3529
2021-08-10 2021-06-30 13F Abbvie Common stock 00287Y109 46,721 -66,610 -58.77 5,263 -57.09 1.3885
2021-05-13 2021-03-31 13F Abbvie Common stock 00287Y109 113,331 69,351 157.69 12,265 160.29 1.5828
2021-02-16 2020-12-31 13F Abbvie Common stock 00287Y109 43,980 -3,674 -7.71 4,712 12.89 1.4431
2020-11-12 2020-09-30 13F Abbvie Common stock 00287Y109 47,654 -6,633 -12.22 4,174 -21.69 1.4665
2020-08-14 2020-06-30 13F Abbvie Common stock 00287Y109 54,287 -25,046 -31.57 5,330 -11.83 1.9910
2020-05-14 2020-03-31 13F AbbVie Common stock 00287Y109 79,333 -18,831 -19.18 6,045 -30.45 2.5373
2020-03-04 2019-12-31 13F AbbVie Common stock 00287Y109 98,164 3,323 3.50 8,691 21.03 1.9368
2019-11-14 2019-09-30 13F ABBVIE INC COM Common stock 00287Y109 94,841 70,440 288.68 7,181 304.79 1.7981
2019-08-15 2019-06-30 13F ABBVIE INC COM Common stock 00287Y109 24,401 -31,270 -56.17 1,774 -60.46 0.9787
2019-05-15 2019-03-31 13F ABBVIE INC COM Common stock 00287Y109 55,671 55,671 4,487 1.9513
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.